store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-863233 HCl 是一种ATP 竞争性 Cdc7 抑制剂(IC50 : 3.4 nM),具有有效性和选择性。BMS-863233 HCl 对 CK2 和 PIM1 具有抑制作用, IC50 值分别为 215 和 42 nM。BMS-863233 HCl 对 pMCM 的 EC50 值为 118 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 418 | 现货 | ||
5 mg | ¥ 987 | 现货 | ||
10 mg | ¥ 1,570 | 现货 | ||
25 mg | ¥ 2,830 | 现货 | ||
50 mg | ¥ 4,190 | 现货 | ||
100 mg | ¥ 5,890 | 现货 | ||
500 mg | ¥ 12,300 | 现货 |
产品描述 | BMS-863233 HCl is an ATP-competitive Cdc7 inhibitor (IC50: 3.4 nM) that is potent and selective.BMS-863233 HCl inhibited CK2 and PIM1 with IC50 values of 215 and 42 nM, respectively.BMS-863233 HCl showed an EC50 value of 118 against pMCM. |
靶点活性 | CK2:215 nM, CDC7:3.4 nM, pMCM:118 nM(EC50), Pim1:42 nM |
体外活性 |
BMS-863233 HCl shows cytotoxic effects on tumors, with IC50 of 22.9 µM in HCC1954 cells and 1.1 µM in Colo-205 cells.[2] BMS-863233 HCl is an effective DDK inhibitor in vitro, with an IC50 of 22.7 nM.[2] BMS-863233 HCl is defective in inhibiting DDK-dependent Mcm2 phosphorylation in HCC1954 cells but is effective in Colo-205 cells.[2] |
体内活性 |
BMS-863233 HCl (10, 30, or 100 mg/kg; p.o.; mice) is well tolerated at all doses, with no significant body weight loss.[1] BMS-863233 HCl (100 mg/kg; p.o.; mice) show excellent plasma exposures in mice and possesses good PK properties.[1] |
别名 | XL413 hydrochloride |
分子量 | 326.18 |
分子式 | C14H13Cl2N3O2 |
CAS No. | 1169562-71-3 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 9.0 mg/mL (27.6 mM), Sonication is recommended.
DMSO: 3.1 mg/mL (9.4 mM), Sonication and heating are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 3.0658 mL | 15.329 mL | 30.6579 mL | 76.6448 mL |
5 mM | 0.6132 mL | 3.0658 mL | 6.1316 mL | 15.329 mL | |
H2O | 10 mM | 0.3066 mL | 1.5329 mL | 3.0658 mL | 7.6645 mL |
20 mM | 0.1533 mL | 0.7664 mL | 1.5329 mL | 3.8322 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BMS-863233 HCl 1169562-71-3 Cell Cycle/Checkpoint Chromatin/Epigenetic JAK/STAT signaling Metabolism Stem Cells CDK Pim Casein Kinase XL413 hydrochloride XL413 Hydrochloride XL 413 Hydrochloride XL-413 Hydrochloride Inhibitor inhibitor inhibit